AGA issues ulcerative colitis medical management guideline — 3 insights

The American Gastroenterological Association published a guideline on medical management of ulcerative colitis in Gastroenterology.

What you should know:

1. The guideline focuses on using oral and topical 5-aminosalicylates medications, rectal corticosteroids and oral budesonide to provide high-quality care.

2. The guideline is intended for patients with mild-to-moderate ulcerative colitis, but the treatments could have varying degrees of effectiveness among patients.

3. AGA does not address biologic therapies and/or immunomodulators with this guideline.

To view the entire guideline, click here.

More articles on gastroenterology:
The outlook is bright for orthopedic investments, analyst says: 4 things to know
Brooklyn Surgery Center partners with Fellow Health Partners for billing services — 3 insights
4 healthcare design trends to watch in 2019

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months